Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 18, 2011
Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendationsC Hermans, P De Moerloose, K Fischer, et al.
Hamostaseologie|December 18, 2013
Recruitment update of AHEADJ Oldenburg, R Zimmermann, A Huth-Kühne, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 21, 2007
Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome dataM Richards, C Altisent, A Batorova, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 22, 2017
Co-morbidities and bleeding in elderly patients with haemophilia-A survey of the German, Austrian and Swiss Society of Thrombosis and Haemostasis Research (GTH)W Miesbach, S-E Reitter-Pfoertner, R Klamroth, et al.
Hamostaseologie|May 1, 2009
[Relevance of a single dose of 270 microg/kg recombinant factor VIIa for the treatment of patients with haemophilia and inhibitors - Recommendations from the GTH experts]Günter Auerswald, W Muntean, B Kemkes-Matthes, et al.
Journal of Thrombosis and Haemostasis : JTH|March 19, 2016
Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 studyS Werwitzke, U Geisen, U Nowak-Göttl, et al.
British Journal of Haematology|December 8, 2011
Neonatal bleeding in haemophilia: a European cohort studyM Richards, G Lavigne Lissalde, C Combescure, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2007
Efficacy, safety and tolerability of recombinant factor VIII (REFACTO) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and AustriaH Pollmann, D Externest, A Ganser, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 29, 2017
PK-guided personalized prophylaxis with Nuwiq<sup>®</sup> (human-cl rhFVIII) in adults with severe haemophilia AT Lissitchkov, L Rusen, P Georgiev, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2007
ReFacto and Advate: a single-dose, randomized, two-period crossover pharmacokinetics study in subjects with haemophilia AJ Di Paola, M P Smith, R Klamroth, et al.
Pageof 5